Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Sarcoma × Zoledronic Acid × Clear all

Phase

Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 24 Prostatic Neoplasms 12 Neoplasm Metastasis 11 Multiple Myeloma 8 Osteoporosis 7 Pain 6 Fractures, Bone 4 Neoplasms, Plasma Cell 3 Lung Neoplasms 3 Humoral Hypercalcemia Of Malignancy 3 Carcinoma, Non-Small-Cell Lung 3 Bone Neoplasms 3 Spinal Cord Compression 2 Neoplasms 2 Lymphoma 2 Hematologic Neoplasms 2 Bone Diseases, Metabolic 2 Triple Negative Breast Neoplasms 1 Treatment of Bone Metastases 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Paraproteinemias 1 Osteosarcoma 1 Neoplastic Processes 1 Lymphoma, Non-Hodgkin 1 Imaging Examination Shows at Least One Site With Bone Metastases From Soild Tumors 1 Hematologic Diseases 1 Giant Cell Tumor of Bone 1 Disease Progression 1

Interventions

Doxorubicin 22 Ifosfamide 19 Radiotherapy 14 Vincristine 9 Etoposide 9 Filgrastim 8 Cyclophosphamide 8 Trabectedin 7 Dactinomycin 7 pazopanib 4 Cisplatin 4 Topotecan 3 Radiation 3 Irinotecan 3 Granulocyte Colony-Stimulating Factor 3 Chemotherapy, Adjuvant 3 sargramostim 2 etoposide phosphate 2 eribulin 2 Observation 2 Methotrexate 2 Mesna 2 Imatinib Mesylate 2 Gemcitabine 2 Docetaxel 2 Dexrazoxane 2 Dacarbazine 2 trofosfamide 1 trioctyl phosphine oxide 1 trametinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00470223 2025-06-08

OS2006

UNICANCER

Phase 3 Active not recruiting

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡